HALOPERIDOL

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID918
Ligand NameHALOPERIDOL
PubMed Compound Id3559
StructureProduct Image
Molecular FormulaC21H23ClFNO2
Molecular Weight375.9
SMILESC1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F
Synonymshaloperidol
52-86-8
Haldol
Serenace
Aloperidin
Eukystol
Aloperidol
Brotopon
Serenase
Serenelfi
Linton
Dozic
Einalon S
Aloperidolo
Galoperidol
Halopoidol
Halojust
Halopal
Keselan
Mixidol
Ulcolind
Uliolind
Pernox
Sernas
Sernel
Aldo
Bioperidolo
Lealgin compositum
Sigaperidol
Peluces
Haldol Solutab
Aloperidon
Haloperidolum
Fortunan
Halosten
McN-JR-1625
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one
Halol
R-1625
177716-59-5
Neurodol
4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one
NSC 170973
Haloperidolum [INN-Latin]
R 1625
CCRIS 1630
1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine
HSDB 3093
EINECS 200-155-6
4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone
4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone
NSC 615296
NSC-170973
NSC-615296
UNII-J6292F8L3D
BRN 0331267
CHEBI:5613
Haloperidol (Haldol)
DTXSID4034150
4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone
J6292F8L3D
1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-
4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone
CHEMBL54
MFCD00051423
NSC170973
Haldol (TN)
4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone
MLS000028450
DTXCID2014150
4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone
4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone
4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone
gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone
5-21-02-00377 (Beilstein Handbook Reference)
Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-
1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-
VESALIUM COMPONENT HALOPERIDOL
NSC615296
CAS-52-86-8
Haloperidol [USAN:USP:INN:BAN:JAN]
NCGC00015500-10
Aloperidolo [DCIT]
Halidol
Halopidol
Pekuces
SMR000058303
C21H23ClFNO2
Aloperidolo [Italian]
Epoxy resins
4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
MDMO-PPV
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one
4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one
Haloperidolum (INN-Latin)
HALOPERIDOL (MART.)
HALOPERIDOL [MART.]
HALOPERIDOL (USP-RS)
HALOPERIDOL [USP-RS]
HALOPERIDOL (EP MONOGRAPH)
HALOPERIDOL (USP IMPURITY)
HALOPERIDOL [EP MONOGRAPH]
HALOPERIDOL [USP IMPURITY]
HALOPERIDOL (USP MONOGRAPH)
HALOPERIDOL [USP MONOGRAPH]
Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-
Haloperidol (USAN:USP:INN:BAN:JAN)
SR-01000003076
Duraperidol
4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone
gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone
4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone
Picroside-III
Haloperidol, 1
4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidyl)-1-(4-fluorophenyl)-butan-1-one
Haloperidol, powder
Prestwick_250
PS14 - Haloperidol
Haloperidol (Standard)
Spectrum_000861
Tocris-0931
starbld0018801
Opera_ID_446
HALOPERIDOL [MI]
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)
Prestwick0_000115
Prestwick1_000115
Prestwick2_000115
Prestwick3_000115
Spectrum2_001268
Spectrum3_000448
Spectrum4_000570
Spectrum5_000788
HALOPERIDOL [INN]
HALOPERIDOL [JAN]
Lopac-H-1512
HALOPERIDOL [HSDB]
HALOPERIDOL [USAN]
Biomol-NT_000035
GTPL86
Probes1_000255
Probes2_000296
H 1512
HALOPERIDOL [VANDF]
SCHEMBL8264
Lopac0_000583
Oprea1_509923
BSPBio_000130
BSPBio_002096
HALOPERIDOL [WHO-DD]
HALOPERIDOL [WHO-IP]
KBioGR_000980
KBioGR_002390
KBioSS_001341
KBioSS_002395
MLS001146904
BIDD:GT0128
DivK1c_000654
SPECTRUM1500325
SPBio_001236
SPBio_002069
McM-JR-1625
BPBio1_000144
BPBio1_001231
Haloperidol (JP18/USP/INN)
Haloperidol - Bio-X trade mark
BDBM21398
Haloperidol, 1mg/ml in Methanol
HMS502A16
KBio1_000654
KBio2_001341
KBio2_002390
KBio2_003909
KBio2_004958
KBio2_006477
KBio2_007526
KBio3_001316
KBio3_002869
LNEPOXFFQSENCJ-UHFFFAOYSA-
HALOPERIDOL [ORANGE BOOK]
N05AD01
cMAP_000037
Haloperidol for system suitability
NINDS_000654
AC250
Haloperidol for peak identification
HMS1568G12
HMS1920D03
HMS2089M15
HMS2091J09
HMS2095G12
HMS2234P08
HMS3261F08
HMS3370H11
HMS3657I13
HMS3712G12
Pharmakon1600-01500325
BCP33202
Haloperidol 1.0 mg/ml in Methanol
STR04750
Tox21_110162
Tox21_300475
Tox21_500583
CCG-36042
CCG-39111
HALOPERIDOLUM [WHO-IP LATIN]
HY-14538R
NSC757054
STL417208
AKOS000280660
Samarium(III) acetylacetonate xhydrate
Tox21_110162_1
AT13670
CS-1971
DB00502
FH23734
LP00583
NSC-757054
SDCCGSBI-0050565.P005
HALOPERIDOL COMPONENT OF VESALIUM
IDI1_000654
MRF-0000027
QTL1_000042
WLN: T6NTJ A3VR DF& DQ DR DG
NCGC00015500-01
NCGC00015500-02
NCGC00015500-03
NCGC00015500-04
NCGC00015500-05
NCGC00015500-06
NCGC00015500-07
NCGC00015500-08
NCGC00015500-09
NCGC00015500-11
NCGC00015500-12
NCGC00015500-13
NCGC00015500-14
NCGC00015500-15
NCGC00015500-16
NCGC00015500-17
NCGC00015500-19
NCGC00015500-24
NCGC00015500-32
NCGC00016234-01
NCGC00023875-02
NCGC00023875-04
NCGC00023875-05
NCGC00023875-06
NCGC00023875-07
NCGC00023875-08
NCGC00023875-09
NCGC00254503-01
NCGC00261268-01
AC-19691
BH166165
DA-74000
HY-14538
SY052276
SBI-0050565.P004
Haloperidol decanoate impurity, haloperidol-
SC 170973
AB00052008
EU-0100583
H0912
NS00010402
S1920
SW196557-4
C01814
D00136
VU0239704-10
AB00052008-21
AB00052008-22
AB00052008_23
AB00052008_24
L000288
Q251347
SR-01000003076-2
SR-01000003076-8
BRD-K67783091-001-04-8
BRD-K67783091-001-05-5
BRD-K67783091-001-25-3
BRD-K67783091-001-26-1
BRD-K67783091-003-03-6
BRD-K67783091-003-07-7
HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]
SR-01000003076-11
Z1590789254
Haloperidol, European Pharmacopoeia (EP) Reference Standard
.gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone
HALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY]
Haloperidol, United States Pharmacopeia (USP) Reference Standard
.gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone
4-(4-HYDROXY-4'-CHLORO-4-PHENYLPIPERIDINO)-4'-FLUORBUTYROPHENONE
Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone
Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard
Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard
200-155-6
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone;R-1625;Aloperidin
4-4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl-1-(4-fluorophenyl)-1-butanone;R-1625;Aloperidin
InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
Poly[2-methoxy-5-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)-1,4-phenylenevinylene]
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm